4basebio PLC (AIM:4BB)
970.00
+21.00 (2.16%)
Jul 28, 2025, 4:35 PM GMT+1
4basebio Revenue
In the year 2024, 4basebio had annual revenue of 933.00K GBP with 84.39% growth. 4basebio had revenue of 605.00K in the half year ending December 31, 2024, with 421.55% growth.
Revenue
933.00K
Revenue Growth
+84.39%
P/S Ratio
160.91
Revenue / Employee
8.48K
Employees
110
Market Cap
150.13M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 933.00K | 427.00K | 84.39% |
Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
Dec 31, 2020 | 462.00K | -346.00K | -42.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |